Company / Capital Expenditures
LIFECORE BIOMEDICAL, INC. \DE\ Capital Expenditures History
FY2012-FY2019 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$23.0M
FY2019
5-year range
$8.9M / $39.7M
FY2015-FY2019
Trend
-42.1%
vs FY2018
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Capital Expenditures has fluctuated over the past 8 years, ranging from $5M in FY2012 to $40M in FY2018.
Based on SEC 10-K filings.
$23M in FY2019 with a 5-year CAGR of +33.8%.
Improved from $18M to $23M over the past 2 years.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- +15.6%
- 5-Year CAGR
- +33.8%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +33.8%, indicating consistent growth.
- In FY2019, capital expenditures decreased 42.1% year-over-year.
- Peak capital expenditures was recorded in FY2018.
- Lowest capital expenditures in the period was in FY2012.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2019 | $23.0M | -42.1% |
| FY2018 | $39.7M | +126.7% |
| FY2017 | $17.5M | +17.6% |
| FY2016 | $14.9M | +67.7% |
| FY2015 | $8.9M | +65.3% |
| FY2014 | $5.4M | -19.6% |
| FY2013 | $6.7M | +28.7% |
| FY2012 | $5.2M | - |
As of FY2019 · SEC 10-K · Updated Jun 24, 2026